首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Lupus Science & Medicine

Lupus Science & Medicine杂志,由BMJ PUBLISHING GROUP出版,1 issue/year,出版语言English,ISSN:2053-8790,E-ISSN:2053-8790。

投稿咨询
Lupus Science & Medicine
Lupus Science & Medicine
Lupus Science & Medicine
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
4.2
CiteScore
5.3
期刊收录
SCI、SCIE

Lupus Science & Medicine(中文译名:《狼疮科学与医学》),ISSN:2053-8790,EISSN:2053-8790,是BMJ PUBLISHING GROUP出版的国际性学术期刊,以1 issue/year形式稳定发行,2026年总发文量约152篇。该刊采用OA开放访问,学科归属为RHEUMATOLOGY。该刊是医学、风湿病学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达4.2,2025年期刊CiteScore为5.3,2025年期刊自引率约4.8%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Lupus Science & Medicine长期聚焦医学、风湿病学及相关产业的技术应用前沿,平均审稿周期15 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、风湿病学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、Sweden、Canada、Australia、CHINA MAINLAND、GERMANY (FED REP GER)等为核心发文国家与地区;JOHNS HOPKINS UNIVERSITYUNIVERSITY OF CALIFORNIA SYSTEM、NEW YORK UNIVERSITY、COLUMBIA UNIVERSITY、NORTHWELL HEALTH、OKLAHOMA MEDICAL RESEARCH FOUNDATION、HARVARD UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
RHEUMATOLOGY 风湿病学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
RHEUMATOLOGY 风湿病学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
RHEUMATOLOGY 风湿病学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RHEUMATOLOGY SCIE Q1 13 / 58

78.4

学科:RHEUMATOLOGY SCIE Q1 10 / 58

83.62

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:RHEUMATOLOGY SCIE Q1 14 / 57

76.3

学科:RHEUMATOLOGY SCIE Q1 14 / 57

76.32


中国学者近期发文

1
Demographic and clinical characteristics of patients with systemic lupus erythematosus across five registries: the LupusNet federated data networ

Author:Zazzetti, Federico; Orillion, Ashley; Sbarigia, Urbano; Sheahan, Anna; Blacketer, Clair; van Speybroeck, Michel; Gasman, Sarah; Sonmez, Reyhan; Noss, Erika H.; Ugarte-Gil, Manuel F.; Gamboa-Cardenas, Rocio Violeta; Pimentel-Quiroz, Victor; Pons-Estel, Guillermo J.; Quintana, Rosana; Saurit, Veronica; Pisoni, Cecilia Nora; Monticielo, Odirlei Andre; Ribeiro, Francinne Machado; Esquivel-Valerio, Jorge A.; Nunez-Alvarez, Carlos A.; Zuniga, Katiuzka; Rebella, Martin; Michaud, Kaleb; Katz, Patricia; Kandane-Rathnayake, Rangi; Morand, Eric F.; Louthrenoo, Worawit; Hoi, Alberta; Nikpour, Mandana; Navarra, Sandra; Lau, Chak Sing; Luo, Shue-Fen; Hamijoyo, Laniyati; Li, Zhanguo; Pego-Reigosa, Jose Maria; Rua-Figueroa, Inigo; Plaza, Zulema; Galindo Izquierdo, Maria; Martinez-Barrio, Julia; Calvo Alen, Jaime; Fernandez-Nebro, Antonio; Menor-Almagro, Raul; Tomero, Eva; Narvaez Garcia, Francisco Javier

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001881

2
Unsupervised clustering of clinical and laboratory features of systemic lupus erythematosus: insights from a multicentre cohor

Author:Hou, Yuke; Wang, Yan; Wei, Bo; Chen, Yinghua; Weng, Chenghua; Wu, Shiyu; Liang, Jingyuan; Zhai, Yujia; Wang, Ping; Zou, Yadan; Gao, Guanmin; Jin, Shanzhao; Li, Jiachen; Zang, Sitian; Li, Xinxin; Cheng, Jianhui; Yao, Haihong; Liu, Zhichun; Wang, Guochun; Liu, Zhi-Hong; Li, Zhanguo

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001842

3
Mechanistic study of compound Muniziqi granule on lupus nephritis in MRL/lpr mice: insights from transcriptomics and experimental validatio

Author:Zhang, Jiyun; Wang, Yuming; Gong, Cuiting; Tabushi, Nuerxiati; Cui, Tianxiao; Ma, Dehong; Qimuk, Yerdin; Pei, Huan; Zhou, Xiaojuan; Wen, Weibo; Wan, Qianqian; Cui, Huantian

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001821

4
Twelve-month follow-up after telitacicept withdrawal in patients with SLE: a single-centre stud

Author:Fan, Zhaoyang; Wei, Yi; Guo, Chunting; Qiao, Lin; Li, Xiangling; Zhang, Fengchun; Fan, Xiaohong; Wang, Li

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001852

5
Left Ventricular Mass Index as an independent predictor of major adverse cardiovascular and cerebrovascular events in patients with SL

Author:Chen, Jie; Zhou, Xiaoli

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001798

6
Sex-based clinical and immunological differences across lupus erythematosus subtypes: a cross-sectional multicentre study from Chin

Author:Pan, Yu; Jin, Hui; Zhou, Shihang; Ying, Zhang; Bai, Leilei; Lu, Qianjin

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001783

7
Statin therapy in systemic lupus erythematosus: a meta-analysis of disease activity and inflammatory biomarker

Author:Qian, Suhai; Wu, Jingyi; Hu, Chao; Luo, Yuanyuan; Chang, Runyu; Liu, Ting; Ding, Xinghong

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001770

8
Serum S100A8 as a potential biomarker for diagnosis of antiphospholipid syndrome and risk stratification among aPL carrier

Author:Luo, Liang; Wang, Yuebing; Zhu, Wenhua; Liu, Xiangjun; Zhu, Lei; Li, Ru; Li, Chun

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001873

9
Intrathecal injection of rituximab inhibits microglial M1 polarisation to alleviate neuropsychiatric SLE symptoms via the cAMP/PKA/CREB signalling pathwa

Author:Li, Chunyan; Yu, Wang; Li, Anmao; Chen, Yong; Zhao, Jing; Lin, Yupei; Pan, Xiao Li; Tian, Mei

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001774

10
Trajectories of long-term eGFR and proteinuria in lupus nephritis: a real-world biopsy-proven cohort stud

Author:Ning, Wei; Liang, Peng-wu; Cao, Tong-tao; Wen, Zhao-han; Liu, Yu; Wang, Ke-er; Luo, Xin-hang; Su, Ruo-wen; Qi, Yuan-yuan; Zhao, Zhan-zheng

Journal: LUPUS SCIENCE & MEDICINE. 2026; Vol. 13, Issue 1, pp. -. DOI: 10.1136/lupus-2025-001745


在线咨询

Lupus Science & Medicine

国际简称:LUPUS SCI MED参考译名:狼疮科学与医学

年发文量:152 CiteScore:5.3 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:96.05%

杂志社联系方式:BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND, WC1H 9JR

Lupus Science & Medicine